Psoriatic Arthritis

Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
Laura C Coates, Josef S Smolen, Philip J Mease, M. Elaine Husni, Joseph F. Merola, Eric Lespessailles, Mitsumasa Kishimoto, Lisa Macpherson, Andrew J Bradley, Rebecca Bolce, Philip S. Helliwell

RMD Open Sep 2022, 8 (2) e002457; DOI: 10.1136/rmdopen-2022-002457
Separating the effects of childhood and adult body size on inflammatory arthritis: a Mendelian randomisation study
Sizheng Steven Zhao, John Bowes, Anne Barton, George Davey Smith, Tom Richardson

RMD Open Aug 2022, 8 (2) e002321; DOI: 10.1136/rmdopen-2022-002321
Multimodal imaging of the distal interphalangeal-joint synovio-entheseal complex in psoriatic arthritis (MIDAS): a cross-sectional study on the diagnostic accuracy of different imaging modalities comparing psoriatic arthritis to psoriasis and osteoarthritis
Jørgen Guldberg-Møller, Mette Mogensen, Karen Ellegaard, Ali Zavareh, Richard J Wakefield, Ai Lyn Tan, Mikael Boesen, Jamshid Dehmeshki, Olga Kubassova, Lene Dreyer, Marius Henriksen, Lars Erik Kristensen

RMD Open Mar 2022, 8 (1) e002109; DOI: 10.1136/rmdopen-2021-002109
Systematic review of the use of CRP in clinical trials for psoriatic arthritis: a concern for clinical practice?
Charlotte Houttekiet, Kurt de Vlam, Barbara Neerinckx, Rik Lories

RMD Open Feb 2022, 8 (1) e001756; DOI: 10.1136/rmdopen-2021-001756
Role of clinical and biochemical inflammation in structural progression of patients with psoriatic arthritis
Carina Borst, Farideh Alasti, Josef S Smolen, Daniel Aletaha

RMD Open Dec 2021, 7 (3) e002038; DOI: 10.1136/rmdopen-2021-002038
Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in Germany
Madeline Deike, Ralph Brinks, Stephan Meller, Matthias Schneider, Philipp Sewerin

RMD Open Dec 2021, 7 (3) e001975; DOI: 10.1136/rmdopen-2021-001975
Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
Kurt de Vlam, Alexis Ogdie, Andrew G Bushmakin, Joseph C Cappelleri, Roy Fleischmann, Peter C Taylor, Valderilio Azevedo, Lara Fallon, John Woolcott, Philip J Mease

RMD Open Jul 2021, 7 (2) e001609; DOI: 10.1136/rmdopen-2021-001609
Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study
Veerle Stouten, Sofia Pazmino, P Verschueren, Pavlos Mamouris, René Westhovens, Kurt de Vlam, Delphine Bertrand, Kristien Van der Elst, Bert Vaes, Diederik De Cock

RMD Open Jun 2021, 7 (2) e001671; DOI: 10.1136/rmdopen-2021-001671
Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden
Anton Jonatan Landgren, Mats Dehlin, Lennart Jacobsson, Ulrika Bergsten, Eva Klingberg

RMD Open May 2021, 7 (2) e001568; DOI: 10.1136/rmdopen-2021-001568
The frequency of uveitis in patients with adult versus childhood spondyloarthritis
Matthew Turk, Jacqueline Hayworth, Tatiana Nevskaya, Janet Pope

RMD Open Aug 2020, 6 (2) e001196; DOI: 10.1136/rmdopen-2020-001196

Main menu

Psoriatic Arthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Psoriatic Arthritis

Pages